9.94
price down icon3.21%   -0.33
pre-market  Pre-mercato:  9.92   -0.02   -0.20%
loading

Zevra Therapeutics Inc Azioni (ZVRA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
9.51%
39.66
36.22 34.12 26.06 25.88
Selling, General, and Administrative
20.32%
16.56
20.78 - - -
Costs And Expenses
16.41%
21.05
25.18 22.97 20.37 24.21
Operating Income/Loss
67.83%
16.78
52.15 9.315 4.143 -71.04
Nonoperating Income/Loss
45.75%
-3.983
-7.342 3.351 -5.12 147.94
Income/Loss From Continuing Operations Before Tax
71.44%
12.79
44.80 12.67 -0.977 76.91
Income Tax Expense/Benefit
41.54%
4.042
6.914 0.501 -0.433 2.199
Net Income/Loss
76.90%
8.752
37.89 12.16 -0.544 74.71
Preferred Stock Dividends And Other Adjustments
-
- 0.335 - -
Basic Average Shares
1.28%
59.16
58.41 0.3618 55.95 54.78
Diluted Average Shares
1.84%
61.34
60.23 0.48 55.95 56.32
Basic Earnings Per Share
77.42%
0.14
0.62 0.20 -0.01 1.24
Diluted Earnings Per Share
76.67%
0.14
0.60 0.19 -0.01 1.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
77.18%
0.359
1.573 0.335 - 6.798
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$6.58
price down icon 4.22%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
$8.19
price down icon 8.08%
Capitalizzazione:     |  Volume (24 ore):